Aurinia Pharmaceuticals, Inc. (AUPH)

15.15 -0.18 (-1.17%) USD  |  NASDAQ  |  Jan 09, 16:00
15.17 +0.02 (+0.13%) After-Hours: 20:00
More

Aurinia Pharmaceuticals Operating Income (Quarterly)

Operating Income (Quarterly) Chart

View Operating Income (Quarterly) for AUPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly) Range, Past 5 Years

View Operating Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly) Benchmarks

View Operating Income (Quarterly) Benchmarks
Start Trial
Oncolytics Biotech, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
Xenon Pharmaceuticals, Inc. Upgrade
ProMIS Neurosciences, Inc. Upgrade